• Go to content
  • Go to search
  • Go to menu
République Française. Liberté, Égalité, Fraternité.
Site de l’ANRS, Maladie infectieuses émergentes — Inserm
  • Newsroom
  • Publications
  • Press room
  • Participant area
  • Français
  • English
Submit a project
  • Who are we?
    Who are we? ANRS Infectious emerging diseases (MIE), autonomous agency of Inserm, facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases. Découvrir la rubrique →
    • The agency in brief A central role in infectious diseases research for over 35 years
    • Mission and strategy Supporting research to prevent, understand and treat infectious diseases
    • Facilitating, funding and structuring research ANRS MIE three majors levels of action
    • Organisation and governance ANRS MIE is an agency operating under the specific status of an autonomous agency within Inserm.
    • Scientific commitments and values Patient associations, next generation of scientists, quality and ethical approach, open science
  • Research
    Research Our agency funds, coordinates, evaluates and facilitates research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases. Découvrir la rubrique →
    • Diseases and pathogens Learn more about the diseases and pathogens covered by our research
    • Research projects Information on the projects we fund
    • Scientific facilitation groups Our workgroups bring together researchers and representatives of civil society
    • Innovation Committee Guiding and advising innovative project leaders
  • Infrastructures
    Infrastructures The agency supports a number of research platforms and networks to federate and help shape research in its field Découvrir la rubrique →
    • Research platforms National and international research platforms supported by the agency and designed for the scientific community
    • Thematic networks Clinical research networks and networks of young researchers
    • Data and samples Access to data and biological collections from research promoted by the agency
  • Partnerships
    Partnerships The agency is a member of various networks and forges partnerships with national and international associations, organisations and initiatives Découvrir la rubrique →
    • The ANRS MIE International Network Partner sites, international global health research platforms, ad hoc partnerships
    • Partnerships and initiatives WHO, Ministry of Europe and Foreign Affairs, Global Health EDCTP3 Joint Undertaking, structuring networks
    • International structuring projects Strategic international projects and capacity-building programmes
    • WHO filovirus CORC Fighting epidemics: ANRS MIE leads WHO filovirus CORC
    • Patient associations Collaboration with community stakeholders
  • Funding
    Funding Each year, the agency offers two calls for generic projects and calls for thematic projects. Some are jointly carried out with other research players Découvrir la rubrique →
    • All calls for proposals Agency's current, forthcoming and completed calls for proposals
    • Winning projects and candidates Find out the list of calls for projects previously funded by the agency
    • The ANRS Emerging infectious diseases Start programme Find out the Start programme, here to support and guide the next generation of scientific researchers
  • Disease Outbreak
    Disease Outbreak ANRS MIE is at the forefront of crisis preparedness and response. Découvrir la rubrique →
    • Outbreak Response programme Facilitation and watch procedure for responding to emerging or re-emerging epidemics.
    • Filovirus (Ebola) Outbreak Response Unit This Outbreak Response Unit for several diseases is active since March 2025.
    • Influenza/Flu Outbreak Response unit ANRS MIE continues to follow influenza closely since June 2024.
    • Chikungunya Outbreak Response Unit Opened since January 2025 and still active since the detection of one new case in French Guiana in January 2026.
    • Outbreak Response units Every Outbreak response units, active or inactive.
  • Newsroom
  • Publications
  • Press room
  • Participant area
    • Français
    • English

Submit a project

Search

  1. Homepage
  2. All news

All news

Here you can find all the latest news and events relating to our areas of research.

Share:

  • Share on Twitter
  • Share on Linkedin


Format
Diseases
Country
Disciplines
Fields

260 results

Trier par


  • News

    France has launched its new global health strategy (2023-2027)

    This new strategy is the roadmap for all French parties involved to meet the challenges of global health: achieving the Sustainable Development Goals (SDGs), in particular SDG 3 for the health and well-being of people at all ages. The aim is to defend universal access to health, prevent and combat...

    15 November 2023

  • Press release

    Announcement of the laureates of the Call for Proposals PEPR MIE 2023

    France 2030: 11 winning projects for the 2023 PEPR MIE call for projects, funded to better understand and prepare to respond to emerging infectious diseases for nearly 22 million euros.

    08 November 2023

  • Press release

    Collaboration of the German Center for Infection Research (DZIF) and the French ANRS-Emerging Infectious Diseases (ANRS | MIE) to advance research in infectious diseases

    07 November 2023

  • Press release

    ANRS DOXYVAC: final analysis may modify interim results of this trial assessing the effectiveness of meningococcal B vaccination in preventing gonococcal infections – ANRS | Emerging Infectious Diseases will commission an independent audit

    ANRS | Emerging Infectious Diseases will commission an independent audit

    24 May 2023

  • Press release

    New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Bacterial STIs and proven efficacy of the MVA-BN Vaccine Against Mpox

    27 February 2023

  • Press release

    Favipiravir: a preclinical study shows lack of antiviral efficacy against SARS-CoV-2 but potential utility against Zika

    A study by researchers from the French Alternative Energies and Atomic Energy Commission (CEA), Inserm and University Paris Cité, who are part of the Preclinical Studies Group (GEPC)* set up by ANRS | Emerging Infectious Diseases, evaluated the effects of favipiravir on SARS-CoV-2 and the Zika...

    13 February 2023

  • Event past

    ANRS MIE partner of AFRAVIH 2024

  • Event past

    IAS 2025 : les projets de recherche soutenus par l’ANRS MIE retenus cette année

  • Event past

    Symposium on hepatitis E virus infection

    This is the 3rd symposium of the coordinated action ‘Basic and translational research on viral hepatitis’ (AC42).

  • Previous
  • 1
  • ...
  • ...
  • 26
  • 27
  • 28
  • 29
  • Suivant
République Française. Liberté, Égalité, Fraternité.
ANRS, Maladie infectieuses émergentes — Inserm
Pratical information
  • Newsroom
  • Contact us
  • Join us
  • Site map
Legal
  • Legal information
  • Personal data and cookies
  • Accessibility